"
Team:LZU-China/Safety
From 2013.igem.org
(Difference between revisions)
Membership (Talk | contribs) |
Membership (Talk | contribs) |
||
| Line 6: | Line 6: | ||
/* main color : #ffb600 */ | /* main color : #ffb600 */ | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| Line 81: | Line 64: | ||
/*** center alone ***/ | /*** center alone ***/ | ||
.main-center .alone{border:1px solid #333; padding:20px; padding-left:30px; min-height:300px; color:#FFF; font-size:15px;} | .main-center .alone{border:1px solid #333; padding:20px; padding-left:30px; min-height:300px; color:#FFF; font-size:15px;} | ||
| + | |||
| + | |||
| + | /**** alter igem default setting ***/ | ||
| + | #blank *{ width: 960px; border-style: none; margin: 0 auto; padding: 0; background-color: #000;} | ||
| + | #globalWrapper{ overflow: hidden; background-color: #000;} | ||
| + | #top,#header,h1.firstHeading,#catlinks{display: none;} | ||
| + | #content{width: 960px; background-attachment: scroll; overflow: hidden; border-style: none; background-color: #000;} | ||
| + | #footer-box{position:relative; z-index:100; background:none; border:none;} | ||
| + | #footer-box a{color:#FFF; font-size:13px;} | ||
| + | #footer #f-poweredbyico, #footer #f-copyrightico{display:none;} | ||
| + | #top-section{height:20px; border:none;} | ||
| + | #top-section #p-logo,#top-section .left-menu, #top-section #search-controls{display:none;} | ||
| + | #top-section .right-menu a{font-size:13px; font-weight:bold; color:#FFF; padding:2px 5px 2px 5px; background:none; text-decoration:none;} | ||
| + | #top-section .right-menu a:hover{color:#ffb600;} | ||
| + | #bodyContent h1, #bodyContent h2, #bodyContent h3{ margin-bottom:3px;} | ||
| + | |||
| + | body{height:100px;background-color:#000;} | ||
| + | |||
| + | .body-in{margin:0 auto; overflow:auto; padding-bottom:50px; font-family:"微软雅黑", Arial; width:960px;} | ||
| + | h1,h2,h3,h4,h5,h6{color:#FFF;} | ||
| + | .main-center .alone h1, .main-center .center-right h1{ line-height:60px;} | ||
| + | .main-center .alone h2, .main-center .center-right h2{ line-height:50px;} | ||
| + | .main-center .alone h3, .main-center .center-right h3{ line-height:40px;} | ||
| + | .main-center .alone h4, .main-center .center-right h4{ line-height:30px;} | ||
| + | .main-center .alone h5, .main-center .center-right h5{ line-height:26px;} | ||
| + | .main-center .alone h6, .main-center .center-right h6{ line-height:22px;} | ||
</style> | </style> | ||
| Line 116: | Line 125: | ||
* researcher safety,<br> | * researcher safety,<br> | ||
* public safety, or<br> | * public safety, or<br> | ||
| - | * environmental safety?<br> | + | * environmental safety?<br><br> |
| - | For the sake of our team members' health and the safety environment that we provided for cell growth, all of us strictly obey the observer rules and the law. | + | For the sake of our team members' health and the safety environment that we provided for cell growth, all of us strictly obey the observer rules and the law. <br><br> |
<h3>2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,</h3> | <h3>2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,</h3> | ||
* did you document these issues in the Registry?<br> | * did you document these issues in the Registry?<br> | ||
* how did you manage to handle the safety issue?<br> | * how did you manage to handle the safety issue?<br> | ||
| - | * How could other teams learn from your experience?<br> | + | * How could other teams learn from your experience?<br><br> |
| - | This year, our team doesn't make any of the new parts which may raise any safety issues. | + | This year, our team doesn't make any of the new parts which may raise any safety issues.<br><br> |
<h3>3. Is there a local biosafety group, committee, or review board at your institution?</h3> | <h3>3. Is there a local biosafety group, committee, or review board at your institution?</h3> | ||
* If yes, what does your local biosafety group think about your project?<br> | * If yes, what does your local biosafety group think about your project?<br> | ||
| - | * If no, which specific biosafety rules or guidelines do you have to consider in your country?<br> | + | * If no, which specific biosafety rules or guidelines do you have to consider in your country?<br><br> |
| - | No. But all of our group members have already followed the book, named "Collection of Laws, Regulations and Standards of the People's Republic of China on Biosafety". | + | No. But all of our group members have already followed the book, named "Collection of Laws, Regulations and Standards of the People's Republic of China on Biosafety".<br><br> |
| - | <h3>4、Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</h3> | + | <h3 style="line-height:26px;">4、Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</h3> |
| - | For what I can tell, more detailed division for safety levels could work its way.<br><br> | + | For what I can tell, more detailed division for safety levels could work its way.<br><br><br> |
</div> | </div> | ||
Revision as of 13:43, 27 September 2013
1. Would any of your project ideas raise safety issues in terms of:
* researcher safety,* public safety, or
* environmental safety?
For the sake of our team members' health and the safety environment that we provided for cell growth, all of us strictly obey the observer rules and the law.
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,
* did you document these issues in the Registry?* how did you manage to handle the safety issue?
* How could other teams learn from your experience?
This year, our team doesn't make any of the new parts which may raise any safety issues.
3. Is there a local biosafety group, committee, or review board at your institution?
* If yes, what does your local biosafety group think about your project?* If no, which specific biosafety rules or guidelines do you have to consider in your country?
No. But all of our group members have already followed the book, named "Collection of Laws, Regulations and Standards of the People's Republic of China on Biosafety".
4、Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?
For what I can tell, more detailed division for safety levels could work its way.
LanZhou University | 222 TianShui South Road, ChengGuan District, LanZhou, China, 730000
E-mail:hwang2013@lzu.edu.cn
LanZhou University © 2013 Privacy Policy
E-mail:hwang2013@lzu.edu.cn
LanZhou University © 2013 Privacy Policy
